Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST
ConclusionPERCIST is useful for evaluating therapeutic response to chemoradiotherapy and predicting recurrence and death in HNSCC patients.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | CT Scan | Head and Neck Cancer | HNSCC | Hypopharyngeal Cancer | Laryngeal Cancer | Nasopharyngeal Cancer | Nuclear Medicine | Oropharyngeal Cancer | PET Scan | Skin Cancer | Squamous Cell Carcinoma